PG is currently developing the following drugs: Stannous Fluoride Dentifrice, Sodium Fluoride Dentifrice, Electric Toothbrush, Cetylpyridinium Chloride (Cpc), Manual Toothbrush, Sodium Monofluorophosphate Dentifrice, Stannous Fluoride Dentifrice, Test Stannous Fluoride Dentifrice, 0.76% Sodium Monofluorophosphate Dentifrice, 0.454% Stannous Fluoride Dentifrice. These drug candidates are in various stages of clinical development as the company works toward FDA approval.